Showing results (1-10 of 1,875) with videos related to
Sort By:
Pageof 188
Scandinavian Journal of Immunology|January 1, 1975
Surface markers on human B and T lymphocytes. VII. Rosette formation between peripheral T lymphocytes and lymphoblastoid B-cell linesM Jondal, E Klein, E YefenofInternational Immunology|April 1, 1991
Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivityE Yefenof, B Asjö, E KleinCellular Immunology|September 1, 1984
Complement-dependent cellular cytotoxicity due to alternative pathway C3 activation by the target cell membraneE Yefenof, I Yron, E KleinMolecular Immunology|December 1, 1984
Contribution of activated C3 to lymphocyte-mediated target lysis: complement-dependent cellular cytotoxicityE Yefenof, E Klein, I YronCancer Immunology, Immunotherapy : CII|January 1, 1991
Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide KE Yefenof, E Einat, E KleinInternational Journal of Cancer|May 15, 1976
Interaction of antibody and cell surface localized antigenE Yefenof, I P Witz, E KleinEuropean Journal of Immunology|July 1, 1991
The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18)L Di Renzo, E Yefenof, E KleinMolecular Immunology|December 1, 1990
Contribution of CR3, CD11b/CD18 to cytolysis by human NK cellsE Klein, L Di Renzo, E YefenofEuropean Journal of Immunology|July 1, 1992
Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysisM Kuraya, E Yefenof, G Klein, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectorsO F Ramos, C Kai, E Yefenof, et al.Pageof 188